A patient on montelukast for asthma takes St John's Wort for low mood and experiences worsening asthma symptoms and increased use of inhalers. What is the most likely drug interaction?

Study for the Foundation Year Pharmacy – Clinical Practice Test. Prepare with detailed questions, step-by-step explanations, and test format insights. Enhance your readiness and confidence!

Multiple Choice

A patient on montelukast for asthma takes St John's Wort for low mood and experiences worsening asthma symptoms and increased use of inhalers. What is the most likely drug interaction?

Explanation:
St John’s Wort can act as a strong inducer of hepatic enzymes, especially CYP3A4. Montelukast is broken down by these enzymes, so taking St John’s Wort speeds up its metabolism and lowers its plasma concentration. With less montelukast available, its anti-inflammatory effect in the airways diminishes, so asthma control worsens and the patient may rely more on rescue inhalers. That’s why the most likely interaction is increased metabolism of montelukast, reducing its effectiveness. The idea that St John’s Wort would increase montelukast absorption or that there’s no interaction doesn’t fit the observed worsening control.

St John’s Wort can act as a strong inducer of hepatic enzymes, especially CYP3A4. Montelukast is broken down by these enzymes, so taking St John’s Wort speeds up its metabolism and lowers its plasma concentration. With less montelukast available, its anti-inflammatory effect in the airways diminishes, so asthma control worsens and the patient may rely more on rescue inhalers. That’s why the most likely interaction is increased metabolism of montelukast, reducing its effectiveness. The idea that St John’s Wort would increase montelukast absorption or that there’s no interaction doesn’t fit the observed worsening control.

Subscribe

Get the latest from Passetra

You can unsubscribe at any time. Read our privacy policy